Where Tech Meets Bio
Latest News
Valinor Discovery, a San Francisco-based startup, has launched from stealth with a focus on simulating how patients might respond to therapies—before any clinical testing begins. …
Read More
Lantern Pharma Gets FDA Green Light for AI-Guided Trial Targeting Hard-to-Treat Lung Cancer
The company’s second Phase 1b/2 trial of LP-184 within a month will test the AI-developed small molecule in patients with lung tumors that resist standard …
Read More
OpenAI Introduces Open Benchmark To Assess AI Performance in Realistic Healthcare Scenarios
OpenAI has released HealthBench, an open-source benchmark developed with 262 physicians across 60 countries to evaluate large language models (LLMs) in realistic healthcare interactions. The benchmark …
Read More
Latest News
AI Drug Discovery Company Insilico Medicine Makes Third Bid for Hong Kong IPO
Toronto’s Intrepid Labs Emerges with $11M and AI-Driven Platform to Rebuild Drug Formulation R&D
Scientists Engineer Precision Tool for Mitochondrial DNA Manipulation
Khondrion Secures €5M to Advance Small Molecule Therapy Toward Phase 3 Trial
Iktos Brings its Gen-AI Drug Design Platform to AWS Marketplace
Crown Bioscience Shows 3D Bone Marrow Model to Improve Blood Cancer Drug Testing and Reduce Animal Use
Latest Insights
by Huzaifa Ali
The Importance of Accurate Patient Matching for AI Projects
Artificial intelligence (AI) is revolutionizing healthcare by enhancing workflows, enabling earlier diagnoses, and paving the way for personalized care. However, its success depends on accurate …
Read More
by Megan Deegan
What CROs Cite as Their Top Clinical Trial Challenges and How They Plan to Overcome Them in 2025
In a rapidly evolving clinical research landscape, there is a greater need now more than ever for pharma and biotech companies to outsource trial management …
Read More
How AI, Graphs, and GraphRAG Are Set to Revolutionize Alzheimer's Gene Research and Treatment
by Dominik Tomicevic
Novotech Report: Over 800 Global IPF Trials Since 2020, Led by Asia-Pacific
by BiopharmaTrend
Report: Nearly 80% of Life Sciences Leaders Considering Virtual Models for Observational Research
by BiopharmaTrend
AI in Drug Safety: From Concept to Reality, The Industry's Path Forward
by Dr. Karthik Muthusamy
Marking the Path Ahead: Integrating Oncology Biomarkers Into Clinical Development
by Bea Mann, PhD
Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?
by Andreas Dreps, Bea Mann, PhD
The Future of Advanced Therapeutics: Opportunities and Challenges
by Sai Bhamidipati
What CROs Cite as Their Top Clinical Trial Challenges and How They Plan to Overcome Them in 2025
by Megan Deegan
From Our Partners
Sponsored by
OPTIC
AI Is Key to Democratizing Drug Discovery
Sponsored by
Lantern Pharma
How AI Empowers Biomarker-Driven Clinical Trials
Sponsored by
SpiroChem
Chemistry CROs at a Crossroads: How SpiroChem Is Adapting to Market Shifts in 2025 and Beyond
Sponsored by
MEDSIR
Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs and Precision Medicine in Oncology
Partner Events

London Biotechnology Show 2025
Event Date: June 18, 2025 - June 19, 2025
Location: United Kingdom (Hall N7 & N8 Bett Global, Excel London, Royal Victoria Dock, 1 Western Gateway, London, UK, England, GB, E16 1XL)
Website: Link
Promo Code: 4CPHAK
Read more ›››

Global Clinical Trials Connect 2025
Promo Code: GCTC10 (valid till 2025-05-28)
Read more ›››

The 12th Aging Research & Drug Discovery Meeting The 11th Aging Research & Drug Discovery Meeting
Event Date: Aug. 25, 2025 - Aug. 29, 2025
Location: Denmark (Ceremonial Hall, University of Copenhagen)
Website: Link
Case Studies
Sponsored by
RECEPTOR.AI
AI Becomes a Drop-in Replacement for Docking
Sponsored by
Roivant Sciences
QUAISAR Computational Platform for Designing Targeted Protein Degraders
Sponsored by
RECEPTOR.AI
ArtiDock from Receptor.AI: Next-generation AI Docking That Beats DiffDock and AlphaFold-latest
Sponsored by
Celeris Therapeutics
Application of AI-driven Xanthos Platform for Designing Protein Degraders
Sponsored by
Cyclica
Cyclica's Chemical Probes for DCAF1
Sponsored by
Lantern Pharma
Powering Cancer Drug Discovery and Development Using the Artificial Intelligence and Machine Learning Platform RADR®
Sponsored by
Trialize
Revolutionizing Clinical Trials: How AI and Automation Reduced Study Build Time from Months to Days
Sponsored by
Bioz
Bioz Badges — Advanced Data-Widgets for Confident E-commerce
Interviews
Pioneering the Largest Foundation Model to Transform RNA Research: An Interview with Brendan Frey
This South Korean Company is at the Forefront of AI-driven Drug Discovery
The Synergistic Potential of AI and Synthetic Biology: Interview with S&P Global’s Miriam Fernández
Targeted Protein Degradation: a New Approach to Small Molecule Therapeutics
Most Read
The CRO Industry in Flux: Navigating Technology, Business Models, and Trends in Pharma R&D Outsourcing
14 Companies Using Quantum Theory To Accelerate Drug Discovery (Including 2 Going Public)
11 Notable Companies Enabling Decentralized Clinical Trials
Cortical Labs Launches $35K Biological Computer Built on Human Brain Cells